Magnesia-zirconia based mimetic biomembrane chromatography for predicting human drug absorption

In this paper, a novel mimetic biomembrane chromatography stationary phase of magnesia-zirconia composite matrix were prepared with the Lewis acid-base interaction between phosphatidylcholine's residue phosphonate group and Lewis acid sites of magnesia-zirconia composite; the retention factors of a chemically diverse set of drugs on the new stationary phase were determined; the drugs logK(mbm) values were correlationed with the absorbed fraction of drugs orally administered in humans (%F(a)) and a hyperbolic relationship was obtained. Meanwhile, the relationship between the logK(mbm) values and hydrophobic parameters (logP(oct) and logD(oct)) were discussed. The usefulness of the new column for predicting oral drug absorption in humans is demonstrated by comparing this model with IAM, ILC and BMC models. Results show that the logK(mbm) values have good relationship with logK(W)(IAM), logK(BMC) and have moderate to fair relationship with logK(s) determined on four different ILC column (EPL, PC, PC-PE, PC-PS). Therefore, the logK(mbm) values can provide key information about the transport properties of drugs and this chromatographic model may be applicable for prediction of drug uptake through epithelial cell membranes during the drug discovery process.     

Speciation of phytate ion in aqueous solution. Sequestration of magnesium and calcium by phytate at different temperatures and ionic strengths, in NaCl(aq)

The formation and stability of Mg(2+) and Ca(2+)-phytate complexes was studied potentiometrically using an ISE-H(+) electrode. Measurements were performed at 10 degrees C and 25 degrees C in NaCl(aq) in the ionic strength range 0.1< or =I< or =0.75 mol L(-1). For both magnesium and calcium systems, the formation of ten M(i)PhyH(j)((12-2i-j)-) species was observed in the range 3< or =pH< or =7 with i=1, 2, 3 and j=3, 4, 5 (and i=3, j=2). These species are quite stable; here we report for example some quantitative data for the species Ca(i)PhyH(3)((9-2i)-), i=1, 2, 3 (equilibrium iCa(2+)+H(j)Phy((12-j)-)=Ca(i)PhyH(j)((12-j-2i)-): K(ij)) at I=0.25 mol L(-1) and t=25 degrees C: logK(13)=3.42, logK(23)=6.47 and logK(33)=9.41. The speciation of the Ca(2+)-phytate system was also checked by ISE-Ca(2+) measurements. Dependence on ionic strength was modeled using a simple Debye-Hückel type equation and formation constants were calculated at infinite dilution. The stability constants of complexes formed at pH>7 were estimated using an empirical predictive equation. The sequestering ability of phytate towards Mg(2+) and Ca(2+) was calculated in different experimental conditions and compared with those of other chelating agents.     

Binding of ring-substituted indole-3-acetic acids to human serum albumin

The plant hormone, indole-3-acetic acid (IAA), and its ring-substituted derivatives have recently attracted attention as promising pro-drugs in cancer therapy. Here we present relative binding constants to human serum albumin for IAA and 34 of its derivatives, as obtained using the immobilized protein bound to a support suitable for high-performance liquid chromatography. We also report their octanol-water partition coefficients (logK(ow)) computed from retention data on a C(18) coated silica gel column. A four-parameter QSPR (quantitative structure-property relationships) model, based on physico-chemical properties, is put forward, which accounts for more than 96% of the variations in the binding affinities of these compounds. The model confirms the importance of lipophilicity as a global parameter governing interaction with serum albumin, but also assigns significant roles to parameters specifically related to the molecular topology of ring-substituted IAAs. Bulky substituents at ring-position 6 increase affinity, those at position 2 obstruct binding, while no steric effects were noted at other ring-positions. Electron-withdrawing substituents at position 5 enhance binding, but have no obvious effect at other ring positions.     

Analysis of oligomeric stability of insulin analogs using hydrogen/deuterium exchange mass spectrometry

Insulin analog products for subcutaneous injection are prepared as solutions in which insulin analog molecules exist in several oligomeric states. Oligomeric stability can affect their onset and duration of action and has been exploited in designing them. To investigate the oligomeric stability of insulin analog products having different pharmacokinetics, we performed hydrogen/deuterium exchange mass spectrometry (HDX/MS), which is a rapid method to analyze dynamic aspects of protein structures. Two rapid-acting analogs (lispro and glulisine) incorporated deuteriums more and faster than recombinant human insulin, whereas a long-acting analog (glargine) and two intermediate-acting preparations (protamine-containing formulations) incorporated them less and more slowly. Kinetic analysis revealed that the number of slowly exchanged hydrogens (D(s)) (k<0.01 min(-1)) accounted for the difference in HDX reactivity among analogs. Furthermore, we found correlations between HDX kinetics and pharmacokinetics reported previously. Their maximum serum concentration (C(max)) was linearly correlated with D(s) (r=0.88) and the number of maximum exchangeable hydrogens (D(∞)) (r=0.89). The maximum drug concentration time (t(max)) was also correlated with reciprocals of D(s) and D(∞) (r=0.86 and r=0.96, respectively). Here we demonstrate the ability of HDX/MS to evaluate oligomeric stability of insulin analog products.